Sunshine Biopharma (NASDAQ:SBFM) Posts Earnings Results, Misses Estimates By $9.94 EPS

Sunshine Biopharma (NASDAQ:SBFM) issued its quarterly earnings data on Tuesday. The company reported ($0.94) earnings per share (EPS) for the quarter, missing the consensus estimate of $9.00 by ($9.94), Zacks reports. The company had revenue of $8.44 million during the quarter. Sunshine Biopharma had a negative net margin of 12.07% and a negative return on equity of 16.09%.

Sunshine Biopharma Trading Down 0.7 %

Shares of Sunshine Biopharma stock traded down $0.02 during mid-day trading on Thursday, hitting $2.66. 51,886 shares of the stock were exchanged, compared to its average volume of 127,708. The stock has a market capitalization of $3.25 million, a price-to-earnings ratio of -0.01 and a beta of 1.38. Sunshine Biopharma has a twelve month low of $2.42 and a twelve month high of $637.20. The company has a 50-day simple moving average of $2.96 and a 200 day simple moving average of $1.65.

About Sunshine Biopharma

Sunshine Biopharma, Inc, a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products.